References
- BadowskiMEPerezSEClinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDSHIV AIDS201683745
- BadowskiMPanditNSPharmacologic management of human immunodeficiency virus wasting syndromePharmacotherapy201434886888124782295
- MangiliAMurmanDHZampiniAMWankeCANutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for health living cohortClin Infect Dis200642683684216477562
- National Cancer InstituteNutrition in Cancer Care (PDQ®)–Health Professional Version Available from: https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq#link/_23_tocAccessed August 30, 2017
- TongHIsenringEYatesPThe prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patientsSupport Care Cancer2009171839018551322
- GrotenhermenFPharmacokinetics and pharmacodynamics of cannabinoidsClin Pharmacokinet200342432736012648025
- National Cancer InstituteNCI Thesaurus Available from: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C867Accessed September 01, 2017
- OhDAParikhNKhuranaVCognata SmithCVetticadenSEffect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteersClin Pharmacol2017991728138268
- Marinol (dronabinol capsules) [package insert]North Chicago, ILAbbVie, Inc2017
- Syndros (dronabinol oral solution) [package insert]Chandler, AZInsys Therapeutics, Inc2017
- BealJOlsonRLefkowitzLLong-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexiaJ Pain Symptom Manage19971417149223837
- BealJEOlsonRLaubensteinLDronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJ Pain Symptom Manage199510289977730690
- LindanCPAllenSSerufiliraAPredictors of mortality among HIV-infected women in Kigali, RwandaAnn Intern Med199211643203281733389
- GuenterPMuurahainenNSimonsGRelationships among nutritional status, disease progression, and survival in HIV infectionJ Acquir Immune Defic Syndr1993610113011388105073
- Drugs @ FDA Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018651Accessed September 11, 2017
- HaneyMGundersonEWRabkinJDronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleepJ Acquir Immune Defic Syndr200745554555317589370
- PrentissDPowerRBalmasGTzuangGIsraelskiDMPatterns of marijuana use among patients with HIV/AIDS followed in a public health care settingJ Acquir Immune Defic Syndr2004351384514707790
- BediGFoltinRWGundersonEWEfficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory studyPsychopharmacology (Berl)2010212467568620824270
- FoxKMBrooksJMGandraSRMarkusRChiouCFEstimation of cachexia among cancer patients based on four definitionsJ Oncol2009200969345819587829
- TisdaleMJCachexia in cancer patientsNat Rev Cancer200221186287112415256
- ParikhNKramerWGKhuranaVCognata SmithCVetticadenSBioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteersClin Pharmacol2016815516227785111
- SallanSECroninCZelenMZinbergNEAntiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazineN Engl J Med198030231351386985702
- MeiriEJhangianiHVredenburghJJEfficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomitingCurr Med Res Opin200723353354317355735
- ChangAEShilingDJStillmanRCDelata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluationAnn Intern Med1979916819824293141
- UngerleiderJTAndrysiakTFairbanksLGoodnightJSarnaGJamisonKCannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazineCancer19825046366456284334
- PlasseTFGorterRWKrasnowSHLaneMShepardKVWadleighRGRecent clinical experience with dronabinolPharmacol Biochem Behav19914036957001666930
- NelsonKWalshDDeeterPSheehanFA phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexiaJ Palliat Care19941011418
- JatoiAWindschitlHELoprinziCLDronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group studyJ Clin Oncol200220256757311786587
- StrasserFLuftnerDPossingerKComparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-GroupJ Clin Oncol200624213394340016849753
- MacGregorKJEmbletonJKLacyJEInfluence of lipolysis on drug absorption from the gastro-intestinal tractAdv Drug Deliv Rev19972513346